Capturing and deciphering the molecular signatures of head and neck cancer

Thomas J. Belbin, Roberto A. Lleras, Richard V. Smith, Nicolas F. Schlecht, Jihyeon Lim, Thomas M. Harris, Geoffrey J. Childs, Michael B. Prystowsky

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Head and neck cancer, while relatively uncommon in the United States remains a prevalent condition throughout the world and potentially has substantial quality of life issues for these patients. As a disease classification, head and neck cancer, represents a diverse population of cancers which are linked anatomically, extending from the clavicles to the skull base. There are many histologic types of cancer within this grouping, although the vast majority are squamous cell carcinomas. The most significant disease sites are the oral cavity, oropharynx, larynx and hypopharynx, while other sites, such as the sinuses, are much less common and more heterogeneous. Treatment for head and neck cancer consists of surgery, radiation therapy and chemotherapy, alone or in combination. The decision to use a particular therapeutic regimen has been related to TNM stage, primary site, and comorbidity of the patient. More recently, molecular studies of head and neck cancer, such as global gene expression, methylation status, microRNA and proteomic changes, continue to identify important alterations in the genetic and molecular make-up of these tumors, all of which will be expanded upon in this chapter.

Original languageEnglish (US)
Title of host publicationCancer Genomics: Molecular Classification, Prognosis and Response Prediction
PublisherSpringer Netherlands
Pages97-130
Number of pages34
ISBN (Print)9789400758421, 9400758413, 9789400758414
DOIs
StatePublished - Sep 1 2014

Fingerprint

Head and Neck Neoplasms
Hypopharynx
Neoplasms
Clavicle
Oropharynx
Skull Base
Larynx
MicroRNAs
Proteomics
Methylation
Mouth
Comorbidity
Molecular Biology
Squamous Cell Carcinoma
Radiotherapy
Quality of Life
Gene Expression
Drug Therapy
Therapeutics
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Belbin, T. J., Lleras, R. A., Smith, R. V., Schlecht, N. F., Lim, J., Harris, T. M., ... Prystowsky, M. B. (2014). Capturing and deciphering the molecular signatures of head and neck cancer. In Cancer Genomics: Molecular Classification, Prognosis and Response Prediction (pp. 97-130). Springer Netherlands. https://doi.org/10.1007/978-94-007-5842-1_4

Capturing and deciphering the molecular signatures of head and neck cancer. / Belbin, Thomas J.; Lleras, Roberto A.; Smith, Richard V.; Schlecht, Nicolas F.; Lim, Jihyeon; Harris, Thomas M.; Childs, Geoffrey J.; Prystowsky, Michael B.

Cancer Genomics: Molecular Classification, Prognosis and Response Prediction. Springer Netherlands, 2014. p. 97-130.

Research output: Chapter in Book/Report/Conference proceedingChapter

Belbin, TJ, Lleras, RA, Smith, RV, Schlecht, NF, Lim, J, Harris, TM, Childs, GJ & Prystowsky, MB 2014, Capturing and deciphering the molecular signatures of head and neck cancer. in Cancer Genomics: Molecular Classification, Prognosis and Response Prediction. Springer Netherlands, pp. 97-130. https://doi.org/10.1007/978-94-007-5842-1_4
Belbin TJ, Lleras RA, Smith RV, Schlecht NF, Lim J, Harris TM et al. Capturing and deciphering the molecular signatures of head and neck cancer. In Cancer Genomics: Molecular Classification, Prognosis and Response Prediction. Springer Netherlands. 2014. p. 97-130 https://doi.org/10.1007/978-94-007-5842-1_4
Belbin, Thomas J. ; Lleras, Roberto A. ; Smith, Richard V. ; Schlecht, Nicolas F. ; Lim, Jihyeon ; Harris, Thomas M. ; Childs, Geoffrey J. ; Prystowsky, Michael B. / Capturing and deciphering the molecular signatures of head and neck cancer. Cancer Genomics: Molecular Classification, Prognosis and Response Prediction. Springer Netherlands, 2014. pp. 97-130
@inbook{53af092945a34db3b7b4ccd1659d7245,
title = "Capturing and deciphering the molecular signatures of head and neck cancer",
abstract = "Head and neck cancer, while relatively uncommon in the United States remains a prevalent condition throughout the world and potentially has substantial quality of life issues for these patients. As a disease classification, head and neck cancer, represents a diverse population of cancers which are linked anatomically, extending from the clavicles to the skull base. There are many histologic types of cancer within this grouping, although the vast majority are squamous cell carcinomas. The most significant disease sites are the oral cavity, oropharynx, larynx and hypopharynx, while other sites, such as the sinuses, are much less common and more heterogeneous. Treatment for head and neck cancer consists of surgery, radiation therapy and chemotherapy, alone or in combination. The decision to use a particular therapeutic regimen has been related to TNM stage, primary site, and comorbidity of the patient. More recently, molecular studies of head and neck cancer, such as global gene expression, methylation status, microRNA and proteomic changes, continue to identify important alterations in the genetic and molecular make-up of these tumors, all of which will be expanded upon in this chapter.",
author = "Belbin, {Thomas J.} and Lleras, {Roberto A.} and Smith, {Richard V.} and Schlecht, {Nicolas F.} and Jihyeon Lim and Harris, {Thomas M.} and Childs, {Geoffrey J.} and Prystowsky, {Michael B.}",
year = "2014",
month = "9",
day = "1",
doi = "10.1007/978-94-007-5842-1_4",
language = "English (US)",
isbn = "9789400758421",
pages = "97--130",
booktitle = "Cancer Genomics: Molecular Classification, Prognosis and Response Prediction",
publisher = "Springer Netherlands",

}

TY - CHAP

T1 - Capturing and deciphering the molecular signatures of head and neck cancer

AU - Belbin, Thomas J.

AU - Lleras, Roberto A.

AU - Smith, Richard V.

AU - Schlecht, Nicolas F.

AU - Lim, Jihyeon

AU - Harris, Thomas M.

AU - Childs, Geoffrey J.

AU - Prystowsky, Michael B.

PY - 2014/9/1

Y1 - 2014/9/1

N2 - Head and neck cancer, while relatively uncommon in the United States remains a prevalent condition throughout the world and potentially has substantial quality of life issues for these patients. As a disease classification, head and neck cancer, represents a diverse population of cancers which are linked anatomically, extending from the clavicles to the skull base. There are many histologic types of cancer within this grouping, although the vast majority are squamous cell carcinomas. The most significant disease sites are the oral cavity, oropharynx, larynx and hypopharynx, while other sites, such as the sinuses, are much less common and more heterogeneous. Treatment for head and neck cancer consists of surgery, radiation therapy and chemotherapy, alone or in combination. The decision to use a particular therapeutic regimen has been related to TNM stage, primary site, and comorbidity of the patient. More recently, molecular studies of head and neck cancer, such as global gene expression, methylation status, microRNA and proteomic changes, continue to identify important alterations in the genetic and molecular make-up of these tumors, all of which will be expanded upon in this chapter.

AB - Head and neck cancer, while relatively uncommon in the United States remains a prevalent condition throughout the world and potentially has substantial quality of life issues for these patients. As a disease classification, head and neck cancer, represents a diverse population of cancers which are linked anatomically, extending from the clavicles to the skull base. There are many histologic types of cancer within this grouping, although the vast majority are squamous cell carcinomas. The most significant disease sites are the oral cavity, oropharynx, larynx and hypopharynx, while other sites, such as the sinuses, are much less common and more heterogeneous. Treatment for head and neck cancer consists of surgery, radiation therapy and chemotherapy, alone or in combination. The decision to use a particular therapeutic regimen has been related to TNM stage, primary site, and comorbidity of the patient. More recently, molecular studies of head and neck cancer, such as global gene expression, methylation status, microRNA and proteomic changes, continue to identify important alterations in the genetic and molecular make-up of these tumors, all of which will be expanded upon in this chapter.

UR - http://www.scopus.com/inward/record.url?scp=84932608825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84932608825&partnerID=8YFLogxK

U2 - 10.1007/978-94-007-5842-1_4

DO - 10.1007/978-94-007-5842-1_4

M3 - Chapter

SN - 9789400758421

SN - 9400758413

SN - 9789400758414

SP - 97

EP - 130

BT - Cancer Genomics: Molecular Classification, Prognosis and Response Prediction

PB - Springer Netherlands

ER -